ClinConnect ClinConnect Logo
Search / Trial NCT04201613

Robot-Enhanced Stroke Therapy Optimizes Rehabilitation (RESTORE)

Launched by UNIVERSITY OF CALGARY · Dec 16, 2019

Trial Information

Current as of July 04, 2025

Unknown status

Keywords

Stroke Stroke Rehabilitation Robotic Exoskeleton

ClinConnect Summary

Medically stable stroke subjects will be recruited in the first few days following their stroke. All participants will complete clinical and robotic assessments of neurologic function at 7 time points. Therapy will occur daily (Monday through Friday) for 20 days.

Study participants will be randomly assigned to 1) start robot therapy early or late after stroke and 2)receive one or two hours of robot therapy per treatment day for four weeks, or 3) control group that will receive the current standard of care.

The participant's chart will be reviewed for information about their stroke and rel...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Recent first stroke (ischemic or hemorrhagic)
  • Upper extremity Fugl-Meyer score 15-45
  • Modified Ashworth score of shoulder/elbow less than or equal to 2
  • Able to follow task instructions
  • Visual acuity better than 20/50 in both eyes
  • Able to give consent
  • Able to commit to follow-up
  • Exclusion Criteria:
  • Prior stroke or significant neurologic problem (e.g. Multiple Sclerosis)
  • Pre-existing musculoskeletal injury that will interfere with active therapy
  • Pre-Stroke Modified Rankin Score \> 2
  • Clinical evidence of Unilateral Spatial Neglect on the Behavioural Inattention Test (BIT)
  • Enrollment in a concurrent clinical intervention trial
  • Major co-morbid or concurrent illness such that improvement is unlikely or completion of the protocol as specified is unlikely

About University Of Calgary

The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.

Locations

Calgary, Alberta, Canada

Patients applied

0 patients applied

Trial Officials

Sean Dukelow, MD, PhD

Principal Investigator

University of Calgary

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials